未登录 分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults 2025年美国传染病学会关于COVID-19治疗和管理的临床实践指南更新：成人轻度至中度COVID-19的抗病毒治疗 Shumaker, Amy Hirsch; Bhimraj, Adarsh; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Shafer, Robert W.; Tien, Phyllis C.; Baden, Lindsey R.; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Hardy, Erica J.; Johnson, Steven; Kim, Arthur Y.; Macbrayne, Christine; Martin, Greg S.; Nadig, Nandita; Nakamura, Mari M.; Oliveira, Carlos R.; Pearson, Jeffrey C.; Riley, Laura; Shoham, Shmuel; Tebas, Pablo; Willis, Zachary; Wolf, Joshua; Loveless, Jennifer; Morgan, Rebecca L.; Falck-Ytter, Yngve; Gandhi, Rajesh T. 分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab 2025年美国传染病学会关于COVID-19治疗与管理的临床实践指南更新：巴瑞替尼与托珠单抗 Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Macbrayne, Christine; Nakamura, Mari M.; Oliveira, Carlos R.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Willis, Zachary; Wolf, Joshua; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
分享 收藏
分享 收藏
Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies 与HIV-1储库病毒对自身IgG抗体中和作用的抵抗相关的因素 McMyn, Natalie F.; Varriale, Joseph; Wu, Hanna W. S.; Hariharan, Vivek; Moskovljevic, Milica; Tan, Toong Seng; Lai, Jun; Singhal, Anushka; Lynn, Kenneth; Mounzer, Karam; Tebas, Pablo; Montaner, Luis J.; Hoh, Rebecca; Yu, Xu G.; Lichterfeld, Mathias; Simonetti, Francesco R.; Kovacs, Colin; Deeks, Steven G.; Siliciano, Janet M.; Siliciano, Robert F. 分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness 2025年美国传染病学会关于COVID-19治疗和管理临床实践指南更新：Pemivibart用于暴露前预防，Vilobelimab用于危重疾病，Abatacept或Infliximab用于严重或危重疾病 Bhimraj, Adarsh; Falck-Ytter, Yngve; Baden, Lindsey R.; Bedimo, Roger; Cawcutt, Kelly; Cheng, Vincent Chi-Chung; Chew, Kara W.; Chiotos, Kathleen; Daar, Eric S.; Dzierba, Amy L.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Kim, Arthur Y.; Li, Jonathan Z.; MacBrayne, Christine; Martin, Greg S.; Nadig, Nandita; Nakamura, Mari M.; Pearson, Jeffrey C.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Shumaker, Amy Hirsch; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept 2025年美国传染病学会关于COVID-19治疗和管理的临床实践指南更新：Abatacept Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; Macbrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab 2025年美国传染病学会关于COVID-19治疗与管理的临床实践指南更新：Infliximab Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; Macbrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With Human Immunodeficiency Virus Type 1: ACTG A5357 II期临床试验：长效卡博特韦（Cabotegravir）和VRC07-523LS用于人类免疫缺陷病毒1型成人患者的病毒抑制（ACTG A5357） Taiwo, Babafemi O.; Zheng, Yu; Rodriguez, Katherine; Burke, Leah; Reeves, Jacqueline D.; Scarsi, Kimberly K.; Gama, Lucio; Petropoulos, Christos J.; Belaunzaran-Zamudio, Pablo F.; Wannamaker, Paul; D'Amico, Ronald; Rathod, Parita; Bar, Katharine J.; Tebas, Pablo 分享 收藏
分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab 2025年美国传染病学会关于COVID-19治疗与管理的临床实践指南更新：Vilobelimab Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; MacBrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
分享 收藏
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection Happe, Myra; Lynch, Rebecca M.; Fichtenbaum, Carl J.; Heath, Sonya L.; Koletar, Susan L.; Landovitz, Raphael J.; Presti, Rachel M.; Santana-Bagur, Jorge L.; Tressler, Randall L.; Holman, LaSonji A.; Novik, Laura; Roa, Jhoanna C.; Rothwell, Ro Shauna; Strom, Larisa; Wang, Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M.; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M.; Pandey, Janardan P.; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R.; Lin, Bob C.; Mcdermott, Adrian B.; Boritz, Eli A.; Capparelli, Edmund V.; Coates, Emily E.; Koup, Richard A.; Ledgerwood, Julie E.; Mascola, John R.; Chen, Grace L.; Tebas, Pablo 分享 收藏
分享 收藏
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis 美国传染病学会关于新型冠状病毒肺炎管理的2024临床实践指南更新: Anti-SARS-CoV-2中和抗体Pemivibart用于暴露前预防 Bhimraj, Adarsh; Falck-Ytter, Yngve; Kim, Arthur Y.; Li, Jonathan Z.; Baden, Lindsey R.; Johnson, Steven; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Chiotos, Kathleen; Daar, Eric S.; Dzierba, Amy L.; Glidden, David, V; Hardy, Erica J.; Martin, Greg S.; Macbrayne, Christine; Nadig, Nandita; Nakamura, Mari M.; Shumaker, Amy Hirsch; Tien, Phyllis; Loveless, Jennifer; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 Antibodies Pahus, Marie Host; Zheng, Yu; Olefsky, Maxine; Gunst, Jesper Damsgaard; Tebas, Pablo; Taiwo, Babafemi; Sogaard, Ole S.; Peluso, Michael J.; Lie, Yolanda; Reeves, Jacqueline D.; Petropoulos, Christos J.; Caskey, Marina; Bar, Katharine J. 分享 收藏
Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center Hamilton, Keith W.; Hua, Elvis; Dutcher, Lauren; Fernandez Lynch, Holly; Junker, Paul; Doucette, Abigail G.; Werner, Danielle; Kannel, Ethan Z.; Civitello, Thomas; Gabriel, Peter; Ahya, Vivek N.; Jacobs, Dina A.; Garfall, Alfred; Pratz, Keith; Degnan, Kathleen O.; Blumberg, Emily A.; Capozzi, Donna; Craig, Ethan; Takach, Patricia; Payne, Aimee S.; Geara, Abdallah; Koenig, Helen; Holzman, Lawrence; Tebas, Pablo 分享 收藏
Switch to fixed-dose doravirine (100 mg) with islatravir (075 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial 在HIV-1抗逆转录病毒治疗的病毒学抑制成人中，每天一次使用islatravir (075 mg) 和固定剂量的doravirine (100 mg): 3期，随机，开放标签，非劣效性试验的48周结果 Molina, Jean-Michel; Rizzardini, Giuliano; Orrell, Catherine; Afani, Alejandro; Calmy, Alexandra; Oka, Shinichi; Hinestrosa, Federico; Kumar, Princy; Tebas, Pablo; Walmsley, Sharon; Grandhi, Anjana; Klopfer, Stephanie; Gendrano, Isaias; Eves, Karen; Correll, Todd A.; Fox, Michelle C.; Kim, Jason 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏.png)
LANCET HIV